510(k) K221842

Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF by Roche Diagnostics — Product Code QSE

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 7, 2022
Date Received
June 24, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Alzheimer’S Disease Pathology Assessment Test
Device Class
Class II
Regulation Number
866.5840
Review Panel
IM
Submission Type

In vitro test to determine whether a patient presenting with cognitive impairment and being evaluated for AD and other causes of cognitive decline will test positive or negative for amyloid plaques or neurofibrillary tangles as measured by PET imaging agents.